Capizzi R, Landi F, Milani M, Amerio P
Clinica Dermatologica, Policlinico Universitario Agostino Gemelli, Rome, Italy.
Br J Dermatol. 2004 Aug;151(2):481-4. doi: 10.1111/j.1365-2133.2004.06067.x.
Combination therapy with antiseptics such as benzoyl peroxide (BP) and topical retinoids is widely used as first-line treatment for acne vulgaris (AV). However, these combinations could have a suboptimal skin tolerability. Recently, a new formulation of hydrogen peroxide (HP) 1% in stabilized cream (Crystacide; Mipharm, Milan, Italy) became available. A previous clinical study has shown that HP cream monotherapy presents a better skin tolerability in comparison with BP in patients with mild AV.
To evaluate the tolerability and the efficacy of combination therapy with HP cream and adapalene 0.1% gel in comparison with the combination of BP 4% cream and adapalene 0.1% gel in the treatment of mild to moderate AV.
In a randomized, investigator-blinded trial, 52 patients (mean +/- SD age 25 +/- 6 years; 19 men and 33 women) with AV were randomly assigned to HP cream and adapalene gel (group HP + A) or to BP cream and adapalene gel (group BP + A), for eight consecutive weeks. Efficacy was assessed by total (TL), inflammatory (IL) and noninflammatory (NL) lesion counts performed at baseline and weeks 4 and 8. Tolerability was assessed by evaluating skin erythema, burning and dryness at weeks 4 and 8.
All patients completed the study. At baseline, the mean +/- SD numbers of TL, IL and NL were 44 +/- 9, 25 +/- 7 and 19 +/- 6 in group HP + A and 40 +/- 9, 21 +/- 7 and 19 +/- 9 in group BP + A, respectively. At the end of the treatment period, TL, IL and NL were reduced by 93%, 92% and 95%, respectively, in group HP + A and by 88%, 86% and 90%, respectively, in group BP + A. A significantly (P = 0.0025) greater reduction in NL was observed in group HP + A in comparison with group BP + A. Tolerability was significantly better in group HP + A in comparison with group BP + A (P = 0.02). Skin dryness and burning sensation were more frequent in group BP + A.
The combination of adapalene and HP cream is an effective topical treatment regimen in mild to moderate AV. This combination has shown a better tolerability profile in comparison with the combination of BP and adapalene.
联合使用如过氧化苯甲酰(BP)和外用维甲酸类药物进行治疗,被广泛用作寻常痤疮(AV)的一线治疗方法。然而,这些联合用药的皮肤耐受性可能欠佳。最近,一种新的配方——含1%过氧化氢(HP)的稳定乳膏(Crystacide;意大利米兰Mipharm公司)已上市。此前一项临床研究表明,在轻度AV患者中,HP乳膏单药治疗相比BP具有更好的皮肤耐受性。
评估HP乳膏与0.1%阿达帕林凝胶联合治疗,相较于4% BP乳膏与0.1%阿达帕林凝胶联合治疗,在轻至中度AV治疗中的耐受性和疗效。
在一项随机、研究者设盲的试验中,52例AV患者(平均年龄±标准差25±6岁;19例男性,33例女性)被随机分配至HP乳膏和阿达帕林凝胶组(HP + A组)或BP乳膏和阿达帕林凝胶组(BP + A组),连续治疗8周。在基线、第4周和第8周时,通过计算总皮损数(TL)、炎性皮损数(IL)和非炎性皮损数(NL)评估疗效。在第4周和第8周时,通过评估皮肤红斑、烧灼感和干燥情况来评估耐受性。
所有患者均完成了研究。基线时,HP + A组TL、IL和NL的平均±标准差数值分别为44±9、25±7和19±6,BP + A组分别为40±9、21±7和19±9。在治疗期结束时,HP + A组的TL、IL和NL分别减少了93%、92%和95%,BP + A组分别减少了88%、86%和90%。与BP + A组相比,HP + A组的NL减少更为显著(P = 0.0025)。HP + A组的耐受性显著优于BP + A组(P = 0.02)。BP + A组皮肤干燥和烧灼感更为常见。
阿达帕林与HP乳膏联合是轻至中度AV的一种有效的局部治疗方案。与BP和阿达帕林联合相比,该联合用药显示出更好的耐受性。